Provider

San Francisco-based FareWell is changing its name to Better Therapeutics, a rebranding that reflects the company’s shift in focus from weight loss and disease prevention to digital therapeutics to treat chronic diseases.

Yesterday, Redwood City, California-based HeartFlow, a company that specializes in creating computerized heart models to treat coronary diseases, announced that it landed $240 million in series E funding led by Wellington Management Company and Baillie Gifford & Company.

Food and Drug Administration Commissioner Dr.

As new technologies and consumer-focused strategies continue their takeover of the healthcare industry, health systems will have to adjust their care models or be left in the dust.

A small study recently published in Translational Psychiatry showed that people living with schizophrenia could use a video game paired with an MRI scanner to curb verbal hallucinations.

When Kate Sheridan was 11 years old, a series of complications from Lyme Disease changed her life dramatically.

The FDA announced yesterday that it will permit marketing of Viz.

Since his appointment in early 2017, U.

A recent NHS Digital survey of social workers highlighted that the majority wanted to see easier methods of information-sharing to support their work. A key challenge to achieving this, unsurprisingly, was sharing data with health organisations.

Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA.